Search

Your search keyword '"Andriulli A"' showing total 326 results

Search Constraints

Start Over You searched for: Author "Andriulli A" Remove constraint Author: "Andriulli A" Topic hepatology Remove constraint Topic: hepatology
326 results on '"Andriulli A"'

Search Results

1. Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology

2. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

3. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

4. Systematic review: interferon-free regimens for patients with HCV-related Child C cirrhosis

5. Safety and efficacy of switching from infliximab biosimilar CT-P13 to infliximab biosimilar SB2 in patients with inflammatory bowel disease

6. The 'Hub and Spoke' model has no effect on mortality in acute upper gastrointestinal bleeding: A prospective multicenter cohort study

7. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

8. Identification of recessively inherited genetic variants for pancreatic cancer risk

9. Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs

10. Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?

11. A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study

12. Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study

13. Variation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance

14. Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis

15. Distinguishing features between patients with acute diverticulitis and diverticular bleeding: Results from the REMAD registry

16. Associations between pancreatic expression quantitative trait loci (eQTLs) and pancreatic ductal adenocarcinoma risk

17. Polymorphic variants within non-coding RNA and risk of pancreatic ductal adenocarcinoma

18. Inverted colonic diverticulum (ICD): report of two cases and literature review of a not that unusual endoscopic challenge

20. OC.10.1 THE USE OF PRE-ENDOSCOPIC INTRAVENOUS PROTON PUMP INHIBITORS (PPIS) HAD NO IMPACT ON CLINICAL OUTCOMES IN ACUTE UPPER GASTROINTESTINAL BLEEDING: A PROSPECTIVE MULTICENTER ITALIAN COHORT STUDY

21. T01.01.7 THE USE OF A SPECIALIZED BLEEDING-MANAGEMENT TEAM HAD NO IMPACT ON MORTALITY FOR ACUTE UPPER GASTROINTESTINAL BLEEDING: AN ITALIAN PROSPECTIVE MULTICENTER COHORT STUDY

22. Etiological factors of chronic hepatitis in Italy: a 2014 national survey

23. The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy

24. Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy

25. Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy: Erratum

26. Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis

27. Genetic determinants of telomere length and risk of pancreatic cancer: a PANDoRA study

28. Correction to: Accuracy and inter-observer agreement of the nice and kudo classifications of superficial colonic lesions: a comparative study

29. Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference

30. HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response

31. T06.02.7 SAFETY AND LONG TERM OUTCOME OF SELF EXPANDIBLE METALLIC STENT AS BRIDGE-TO-SURGERY FOR OCCLUSIVE COLORECTAL CANCER

32. An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C

33. Letter: the efficacy of interferon-free regimens in HCV-related Child C cirrhosis needs careful interpretation―Authors' reply

34. HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study

35. Transperineal ultrasonography: First level exam in IBD patients with perianal disease

36. The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study

37. HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome

38. P.03.17 PERCUTANEOUS ULTRASOUND FINE NEEDLE BIOPSY IN SOLID PANCREATIC LESIONS

40. OC.11.5 TRIGGER AND TARGET TRANSFUSION STRATEGY IN PATIENTS WITH NON-VARICEAL ACUTE UPPER GASTROINTESTINAL BLEEDING (NV-AUGIB): A PROSPECTIVE MULTICENTRE OBSERVATIONAL STUDY

41. Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events Registry

42. Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study

43. Screening and treatment of portal vein thrombosis in cirrhosis

44. Forecasting liver disease burden based on a real life cohort of the linked to care patients in Italy. Does the ‘underwater portion of the iceberg’ matter to reach the WHO HCV eliminating goals in the high HCV prevalent countries?

45. OC.14.2 PREDICTIVE FACTORS OF MORTALITY IN ACUTE GASTROINTESTINAL BLEEDING IN ITALY (AUGIB): A NEW PRE-ENDOSCOPY PROGNOSTIC MODEL FROM A MULTICENTER STUDY

46. Forecasting liver disease burden

47. OC.04.3 GENETIC PREDISPOSITION TO COLON CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: NGS APPROACH TO IDENTIFY HIGH RISK PATIENTS

48. P.07.13 SAFETY AND EFFICACY OF INFLIXIMAB BIOSIMILAR SB2 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE WHO UNDERWENT A SWITCH FROM INFLIXIMAB BIOSIMILAR CT-P13

49. Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta

50. Experts' opinions on the role of liver biopsy in HCV infection: A Delphi survey by the Italian Association of Hospital Gastroenterologists (A.I.G.O.)

Catalog

Books, media, physical & digital resources